Search Results for

*

1-13 of 13 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Lofexidine (Lucemyra) for Treatment of Opioid Withdrawal Symptoms - STEPS - American ...

Mar 15, 2019 - Lofexidine has been shown to be as effective as clonidine at controlling some of the symptoms of withdrawal from opioid use. It may have a small additional benefit for maintaining abstinence in patients switched to buprenorphine or methadone for long-term maintenance.

American Family Physician : STEPS

https://www.aafp.org/afp/2019/0315/p392.html

Implantable Buprenorphine (Probuphine) for Maintenance Treatment of Opioid Use Disorder...

May 15, 2018 - Implantable buprenorphine is an expensive alternative for patients on a stable dosage of transmucosal buprenorphine. Based on current research and guidance, implantable buprenorphine should not be used as initial treatment for opioid dependence or as a substitute for medication-assisted...

American Family Physician : STEPS

https://www.aafp.org/afp/2018/0515/p668.html

Vortioxetine (Brintellix) for the Treatment of Depression - STEPS - American Family ...

Mar 1, 2015 - Current evidence does not support the routine use of vortioxetine in the treatment of depression. Family physicians most often encounter patients with mild to moderate depression, and vortioxetine has not been studied in this population. There is no clear benefit of using vortioxetine ...

American Family Physician : STEPS

https://www.aafp.org/afp/2015/0301/p325.html

Suvorexant (Belsomra) for Insomnia - STEPS - American Family Physician

Jun 15, 2016 - Suvorexant effectively increases total sleep time and decreases time to sleep onset. Because of its risk of abuse, significant incidence of next-day impairment, and high cost, it should be reserved for use in patients for whom other insomnia therapies, such as cognitive behavior therapy...

American Family Physician : STEPS

https://www.aafp.org/afp/2016/0615/p1016.html

Levomilnacipran (Fetzima) for Major Depressive Disorder - STEPS - American Family ...

Oct 15, 2015 - Levomilnacipran should not be used in patients with mild to moderate depression until studies have proven its effectiveness. It is somewhat effective in patients with moderate to severe depression. The short-term adverse effect profile of levomilnacipran is similar to that of other SNRIs.

American Family Physician : STEPS

https://www.aafp.org/afp/2015/1015/p727.html

Doxepin (Silenor) for Insomnia - STEPS - American Family Physician

Aug 15, 2011 - In older patients with primary insomnia, Silenor can increase duration of sleep without next-day effects. However, it does not significantly decrease the time to sleep onset, and it is less effective in younger adults.

American Family Physician : STEPS

https://www.aafp.org/afp/2011/0815/p453.html

Vilazodone (Viibryd) for the Treatment of Depression - STEPS - American Family Physician

Aug 15, 2013 - The available evidence does not support the routine use of vilazodone in the treatment of depression. It is significantly more expensive than generic alternatives and is no more effective for moderate to severe depression than selective serotonin reuptake inhibitors or tricyclic ...

American Family Physician : STEPS

https://www.aafp.org/afp/2013/0815/p263.html

Risperidone (Risperdal) for Management of Autistic Disorder - STEPS - American Family ...

Jun 15, 2009 - Risperidone does not alter the course of autistic disorder, but is effective for controlling irritability and other associated symptoms. Patients taking risperidone should be appropriately monitored for adverse effects, especially abnormal movements.

American Family Physician : STEPS

https://www.aafp.org/afp/2009/0615/p1104.html

Ramelteon (Rozerem) for Insomnia - STEPS - American Family Physician

Apr 15, 2006 - Ramelteon is safe and effective for decreasing the time to persistent sleep in patients with chronic insomnia. It does not have the potential for abuse or dependence that sedative hypnotics have and is not a controlled substance.

American Family Physician : STEPS

https://www.aafp.org/afp/2006/0415/p1437.html

Selegiline Transdermal Patch (Emsam) for Major Depressive Disorder - STEPS - American ...

Feb 15, 2008 - Transdermal selegiline is an expensive treatment option for patients with major depressive disorder who have not responded to other antidepressants or who cannot swallow or take oral medications. Based on guidelines from the American Psychiatric Association, MAO inhibitor ...

American Family Physician : STEPS

https://www.aafp.org/afp/2008/0215/p505.html

Acamprosate (Campral) for Treatment of Alcoholism - STEPS - American Family Physician

Aug 15, 2006 - Acamprosate is a safe and well-tolerated treatment for patients with alcoholism and it appears to improve the likelihood that patients will remain abstinent. Most evidence suggests it is as effective as naltrexone but with fewer adverse reactions, and that it may be more effective when ...

American Family Physician : STEPS

https://www.aafp.org/afp/2006/0815/p645.html

Duloxetine (Cymbalta) for Treatment of Major Depressive Disorder - STEPS - American ...

Sep 15, 2005 - Duloxetine is safe and effective for the treatment of major depressive disorder. Because of its expense and the lack of data supporting its superiority over other antidepressants, it should be used as an alternative if other agents are ineffective or are not tolerated.

American Family Physician : STEPS

https://www.aafp.org/afp/2005/0915/p1099.html

Eszopiclone (Lunesta) for Treatment of Transient and Chronic Insomnia - STEPS - ...

Jun 15, 2005 - Similar to other hypnotic drugs, eszopiclone treats the symptom of insomnia and not the underlying cause. It offers no advantage over other nonbenzodiazepine hypnotic agents for transient insomnia and it therefore should be considered a second-line agent.

American Family Physician : STEPS

https://www.aafp.org/afp/2005/0615/p2359.html

Page  1

25 50 100 results per page